Robert Wasserman
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders
Papers in
- Immunology 14
- T-cell and B-cell Immunology 9
- Immune Cell Function and Interaction 5
- Immunodeficiency and Autoimmune Disorders 4
-
- Acute Lymphoblastic Leukemia research 13
- Co-authors
- Richard R. Hardy (8 shared papers)G Rovera (8 shared papers)B A Reichard (6 shared papers)S Shane (8 shared papers)Kyoko Hayakawa (4 shared papers)Masao Yamada (2 shared papers)A J Caton (1 shared paper)Beverly J. Lange (6 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (5 papers)The Journal of Experimental Medicine (4 papers)The Journal of Immunology (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Robert Wasserman
32 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 68
- Hematology 537
- Immunology 945
- Genetics 261
- Public Health, Environmental and Occupational Health 462
- Radiology, Nuclear Medicine and Imaging 314
Countries citing papers authored by Robert Wasserman
This map shows the geographic impact of Robert Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wasserman more than expected).
Fields of papers citing papers by Robert Wasserman
This network shows the impact of papers produced by Robert Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wasserman. The network helps show where Robert Wasserman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wasserman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 333 | |
| 2 | 1996 | 308 | |
| 3 | 1990 | 163 | |
| 4 | 2003 | 134 | |
| 5 | 1998 | 99 | |
| 6 | 1992 | 99 | |
| 7 | 1997 | 92 | |
| 8 | 1992 | 80 | |
| 9 | 1988 | 76 | |
| 10 | 1982 | 71 | |
| 11 | 1992 | 65 | |
| 12 | 1997 | 49 | |
| 13 | 1993 | 45 | |
| 14 | 1995 | 40 | |
| 15 | 1998 | 38 | |
| 16 | 1992 | 28 | |
| 17 | 2005 | 24 | |
| 18 | 1997 | 23 | |
| 19 | 1998 | 15 | |
| 20 | 1998 | 14 |
About Robert Wasserman
Robert Wasserman is a scholar working on Immunology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (13 papers), T-cell and B-cell Immunology (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Immune Cell Function and Interaction (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Hematology (537 citations), Immunology (945 citations), Genetics (261 citations), Public Health, Environmental and Occupational Health (462 citations) and Radiology, Nuclear Medicine and Imaging (314 citations). Robert Wasserman has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Richard R. Hardy, G Rovera, B A Reichard, S Shane, Kyoko Hayakawa, Masao Yamada, A J Caton, Beverly J. Lange, Richard B. Womer and Naomi Galili. Their work appears in journals such as Journal of Clinical Oncology, Blood, The Journal of Experimental Medicine, The Journal of Immunology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.